ABSTRACT
BACKGROUND: Childhood obesity rates in minority populations continue to rise despite leveling national trends. Although interventions that address social and environmental factors exist, processes that create demand for policy and environmental change within communities have not been identified. COMMUNITY CONTEXT: We developed a pilot program in South Omaha, a Nebraska Latino community, based on the community readiness model (CRM), called SaludableOmaha. We used CRM to explore the potential of youth advocacy to shift individual and community norms regarding obesity prevention in South Omaha and to advocate for health-promoting community environments. METHODS: We used CRM to assess supply and demand for health programs, engage the community, determine the community's baseline readiness to address childhood obesity, and guide youth advocacy program development. We conducted our project in 2 phases. In the first, we trained a cohort of youth. In the second, the youth cohort created and launched a Latino health movement, branded as SaludableOmaha. A third phase, which is currently under way, is directed at institutionalizing youth advocacy in communities. OUTCOME: At baseline, the community studied was at a low stage of readiness for change. Our program generated infrastructure and materials to support the growth and institutionalization of youth advocacy as a means of increasing community readiness for addressing obesity prevention. INTERPRETATION: CRM is an important tool for addressing issues such as childhood obesity in underserved communities because it provides a framework for matching interventions to the community. Community partnerships such as SaludableOmaha can aid the adoption of obesity prevention programs.
Subject(s)
Community Networks/statistics & numerical data , Community Participation , Health Promotion , Obesity/prevention & control , Adolescent , Child , Community-Institutional Relations , Female , Health Behavior/ethnology , Hispanic or Latino/psychology , Hispanic or Latino/statistics & numerical data , Humans , Male , Nebraska , Patient Advocacy , Pilot Projects , Program DevelopmentABSTRACT
No disponible
Subject(s)
Humans , Female , Middle Aged , Long QT Syndrome/complications , Long QT Syndrome/diagnosis , Myocardial Ischemia/complications , Catheterization , Cardiac Catheterization/instrumentation , Cardiac Catheterization/methods , Angioplasty, Balloon, Coronary/methods , Angioplasty, Balloon, CoronarySubject(s)
Acute Coronary Syndrome/complications , Long QT Syndrome/etiology , Torsades de Pointes/etiology , Acute Coronary Syndrome/physiopathology , Aged , Cardiac Catheterization , Electrocardiography , Female , Humans , Long QT Syndrome/physiopathology , Myocardial Ischemia/complications , Torsades de Pointes/physiopathologyABSTRACT
El propósito del trabajo fue investigar las variaciones que sufren las pruebas de coagulación y fibronolisis en los enfermos con infarto agudo del miocardio durante el tratamiento trombolítico con activador tisular del plasminógeno (at-PlG) y su relación con complicaciones hemorrágicas. Se estudiaron 17 enfermos a quienes se les administró at-PlG en infusión contínua durante 3 horas y se les practicaron tiempos de protrombina (TP), de tromboplastina y parcial (TTP), de trombina (TT), fibrinógeno (FG), productos de degradación del fibrinógeno (PDF), plasminógeno (PIG), alfa-2-antiplasmina (A-2AP) y antitrombina III (AT-III) durante y después de la aplicación del medicamento. En la mayoría de los casos se prolongaron los tiempos de coagulación, disminuyó tanto el FG como el PlG y se incrementaron los PDF. La a-2-AP y la AT-III no sugrieron modificaciones significativas. El PG se recuperó en las siguientes 3 horas y se presentó hiperfibrinogenemia después del segundo día. No se presentó hemorragia en ningún caso. Las alteraciones de laboratorio observadas no tuvieron expresión hemorrágica. El at-PiG produce menor hipofibrinogenemia que la reportada con otros trombolíticos
